BIO-TECHNE Corp Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
BIO-TECHNE Corp (TECH) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $200.00 thousand for the 12-month period ending 2025-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-08-24
- BIO-TECHNE Corp unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $200.00K, a 66.67% decline from fiscal 2024.
- BIO-TECHNE Corp unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $600.00K, a 20.00% increase from fiscal 2023.
- BIO-TECHNE Corp unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $500.00K.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2025-06-30 | $200.00K 10-K · filed 2026-08-24 |
| 2024-06-30 | $600.00K 10-K · filed 2026-08-24 |
| 2023-06-30 | $500.00K 10-K · filed 2025-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |